Bruno Maranda

4.0k total citations
57 papers, 1.4k citations indexed

About

Bruno Maranda is a scholar working on Molecular Biology, Physiology and Genetics. According to data from OpenAlex, Bruno Maranda has authored 57 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 15 papers in Physiology and 14 papers in Genetics. Recurrent topics in Bruno Maranda's work include Lysosomal Storage Disorders Research (14 papers), Metabolism and Genetic Disorders (11 papers) and Glycogen Storage Diseases and Myoclonus (7 papers). Bruno Maranda is often cited by papers focused on Lysosomal Storage Disorders Research (14 papers), Metabolism and Genetic Disorders (11 papers) and Glycogen Storage Diseases and Myoclonus (7 papers). Bruno Maranda collaborates with scholars based in Canada, United States and France. Bruno Maranda's co-authors include Christiane Auray‐Blais, Paméla Lavoie, Vladimir Marshansky, Ross B. Hodgetts, Patrick Vinay, Sylvain Bourgoin, Rachel Laframboise, Dennis Brown, M Schachter and James E. Casanova and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Physiology and International Journal of Molecular Sciences.

In The Last Decade

Bruno Maranda

53 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruno Maranda Canada 23 714 394 288 260 206 57 1.4k
Christine Barnérias France 20 704 1.0× 283 0.7× 113 0.4× 236 0.9× 156 0.8× 73 1.4k
Esther Leshinsky‐Silver Israel 25 928 1.3× 522 1.3× 103 0.4× 287 1.1× 176 0.9× 76 1.7k
Denise Cassandrini Italy 23 735 1.0× 176 0.4× 252 0.9× 228 0.9× 185 0.9× 62 1.3k
Brendan C. Lanpher United States 17 581 0.8× 465 1.2× 109 0.4× 259 1.0× 70 0.3× 41 1.2k
Tomáš Honzík Czechia 23 1.1k 1.5× 225 0.6× 233 0.8× 524 2.0× 90 0.4× 102 1.6k
Majid Alfadhel Saudi Arabia 28 1.4k 1.9× 920 2.3× 232 0.8× 625 2.4× 218 1.1× 157 2.5k
Ivo Kremensky Bulgaria 18 753 1.1× 295 0.7× 121 0.4× 127 0.5× 152 0.7× 75 1.4k
Sarah Dyack Canada 15 440 0.6× 319 0.8× 161 0.6× 130 0.5× 71 0.3× 37 1.2k
Martin G. Bialer United States 18 547 0.8× 472 1.2× 248 0.9× 95 0.4× 54 0.3× 34 1.3k
Elsebet Østergaard Denmark 26 1.6k 2.2× 298 0.8× 158 0.5× 808 3.1× 147 0.7× 67 2.2k

Countries citing papers authored by Bruno Maranda

Since Specialization
Citations

This map shows the geographic impact of Bruno Maranda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Maranda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Maranda more than expected).

Fields of papers citing papers by Bruno Maranda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Maranda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Maranda. The network helps show where Bruno Maranda may publish in the future.

Co-authorship network of co-authors of Bruno Maranda

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Maranda. A scholar is included among the top collaborators of Bruno Maranda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Maranda. Bruno Maranda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Maranda, Bruno, et al.. (2024). UPLC-MS/MS High-Risk Screening for Sphingolipidoses Using Dried Urine Spots. Biomolecules. 14(12). 1612–1612. 1 indexed citations
3.
Boutin, Michel, Bruno Maranda, & Paula J. Waters. (2024). Analysis of Globotriaosylceramide (Gb3) in Liquid Urine: A Straightforward Assay Using Tandem Mass Spectrometry. Current Protocols. 4(6). e1087–e1087.
4.
Boutin, Michel, et al.. (2022). Lysosphingolipid Urine Screening Test using Mass Spectrometry for the Early Detection of Lysosomal Storage Disorders. Bioanalysis. 14(5). 289–306. 1 indexed citations
5.
Auray‐Blais, Christiane, Michel Boutin, Paméla Lavoie, & Bruno Maranda. (2021). Neonatal Urine Screening Program in the Province of Quebec: Technological Upgrade from Thin Layer Chromatography to Tandem Mass Spectrometry. International Journal of Neonatal Screening. 7(1). 18–18. 7 indexed citations
6.
Boutin, Michel, Paméla Lavoie, Marie‐Françoise Arthus, et al.. (2020). Diurnal Variation of Urinary Fabry Disease Biomarkers during Enzyme Replacement Therapy Cycles. International Journal of Molecular Sciences. 21(17). 6114–6114. 4 indexed citations
7.
8.
Bossé, Yohan, Maxime Lamontagne, Nathalie Gaudreault, et al.. (2019). Early-onset emphysema in a large French-Canadian family: a genetic investigation. The Lancet Respiratory Medicine. 7(5). 427–436. 15 indexed citations
9.
Chénier, Sébastien, Valérie Désilets, Bruno Maranda, et al.. (2018). Clinical validity of phenotype-driven analysis software PhenoVar as a diagnostic aid for clinical geneticists in the interpretation of whole-exome sequencing data. Genetics in Medicine. 20(9). 942–949. 9 indexed citations
10.
Lévesque, Sébastien, Christiane Auray‐Blais, Michel Boutin, et al.. (2016). Diagnosis of late-onset Pompe disease and other muscle disorders by next-generation sequencing. Orphanet Journal of Rare Diseases. 11(1). 8–8. 43 indexed citations
11.
Fernández, Isabel, Natalie Patey, Valérie Marchand, et al.. (2014). Multiple Intestinal Atresia With Combined Immune Deficiency Related to TTC7A Defect Is a Multiorgan Pathology. Medicine. 93(29). e327–e327. 31 indexed citations
12.
Dumoulin, Elaine, David R. Stather, Gary Gelfand, et al.. (2013). Idiopathic Subglottic Stenosis: A Familial Predisposition. The Annals of Thoracic Surgery. 95(3). 1084–1086. 17 indexed citations
13.
Auray‐Blais, Christiane, Paméla Lavoie, Haoyue Zhang, et al.. (2012). An improved method for glycosaminoglycan analysis by LC–MS/MS of urine samples collected on filter paper. Clinica Chimica Acta. 413(7-8). 771–778. 66 indexed citations
14.
Shinawi, Marwan, Trilochan Sahoo, Bruno Maranda, et al.. (2011). 11p14.1 microdeletions associated with ADHD, autism, developmental delay, and obesity. American Journal of Medical Genetics Part A. 155(6). 1272–1280. 71 indexed citations
15.
Lambert, M, Bruno Maranda, Rachel Laframboise, et al.. (2008). Pyruvate Dehydrogenase Deficiency Presenting as Intermittent Isolated Acute Ataxia. Neuropediatrics. 39(1). 20–23. 27 indexed citations
16.
Dhar, Shweta U., Fernando Scaglia, Laurie D. Smith, et al.. (2008). Expanded clinical and molecular spectrum of guanidinoacetate methyltransferase (GAMT) deficiency. Molecular Genetics and Metabolism. 96(1). 38–43. 45 indexed citations
17.
Lambert, M, Régen Drouin, Daphna Fenyves, et al.. (2008). Phenotypic variability among patients with hyperornithinaemia–hyperammonaemia–homocitrullinuria syndrome homozygous for the delF188 mutation in SLC25A15. Journal of Medical Genetics. 45(11). 759–764. 30 indexed citations
18.
Maranda, Bruno, Nicole Lemieux, & Emmanuelle Lemyre. (2006). Familial deletion 18p syndrome: case report. BMC Medical Genetics. 7(1). 60–60. 32 indexed citations
19.
Marshansky, Vladimir, Sylvain Bourgoin, Irene Londoño, et al.. (1997). Receptor‐mediated endocytosis in kidney proximal tubules: Recent advances and hypothesis. Electrophoresis. 18(14). 2661–2676. 36 indexed citations
20.
Caratsch, C. G., Bruno Maranda, Ricardo Miledi, & Peter N. Strong. (1982). Antibodies to β-bungarotoxin and its phospholipase inactive derivative. Proceedings of the Royal Society of London. Series B, Biological sciences. 215(1200). 365–373. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Barnérias Breakdown of academic impact, for papers by Esther Leshinsky‐Silver Breakdown of academic impact, for papers by Denise Cassandrini Breakdown of academic impact, for papers by Brendan C. Lanpher Breakdown of academic impact, for papers by Tomáš Honzík Breakdown of academic impact, for papers by Majid Alfadhel Breakdown of academic impact, for papers by Ivo Kremensky Breakdown of academic impact, for papers by Sarah Dyack Breakdown of academic impact, for papers by Martin G. Bialer Breakdown of academic impact, for papers by Elsebet Østergaard
Rankless by CCL
2026